Notes Payable (Details Narrative) (USD $)	3 Months Ended	0 Months Ended		3 Months Ended	12 Months Ended		0 Months Ended
	Mar. 31, 2014	Jul. 15, 2012	May 01, 2011	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Jun. 26, 2013	Jan. 08, 2015
Debt Instrument [Line Items]
Warrant shares				2,306,032
Warrant Exercise Price								$ 3.40
Repayments of notes payable	$ 59,030
Cash Paid for Interest	9,835
Drug Wholesaler Notes Payable [Member]
Debt Instrument [Line Items]
Debt face amount			147,866
Frequency of periodic payment				monthly
Periodic payment			10,000
Final payment		7,866
Effective stated interest rate				12.00%
Balance due on note	38,653			0		38,653
Notes Payable to Related Party [Member]
Debt Instrument [Line Items]
Effective stated interest rate	10.00%					10.00%
Repayments of notes payable						97,122
Accrued interest	79,776			0		79,776
Cash Paid for Interest					79,776
Secured Convertible Promissory Notes [Member]
Debt Instrument [Line Items]
Gross proceeds from issuance of debt							5,300,000
Warrant shares							764,960
Debt issuance costs							286,349
Debt face amount							6,502,158
Warrants exercisable period							5 years
Warrant Exercise Price				$ 3.40			$ 12.155
Percentage of closing price compare to exercise price							110.00%
Warrant call notice percentage of warrant exercise price				250.00%
Warrants exercise, call notice threshold trading days							10 days
Warrants exercise, consecutive trading days preceding call notice period							20 days
Warrants exercise, trading days after call date							14 days
Estimated fair value of warrants (in dollars per share)							$ 2.329
Estimated fair value of anti-dilution warrants (in dollars per share)							$ 1.2002
Change in Fair Value of Conversion Feature Liability							$ 2,398,280
Secured Convertible Promissory Notes [Member] | Volume weighted average price ("VWAP")
Debt Instrument [Line Items]
Warrant Exercise Price				$ 8.50